The Net Margin of Supernus Pharmaceuticals Inc (SUPN) is 11.16%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 11.16% |
| 2023-12-31 | 0.22% |
| 2022-12-31 | 9.10% |
| 2021-12-31 | 9.21% |
| 2020-12-31 | 24.40% |
| 2019-12-31 | 28.79% |
| 2018-12-31 | 27.15% |
| 2017-12-31 | 18.96% |
| 2016-12-31 | 42.42% |
| 2015-12-31 | 9.42% |